X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1%
Thu, 31 Jan

TORRENT PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m14,77018,94020,5108.3%38.9%
Other incomeRs m74010030-70.0%-95.9%
TurnoverRs m15,51019,04020,5407.9%32.4%
ExpensesRs m11,18014,21014,9004.9%33.3%
Gross profitRs m3,5904,7305,61018.6%56.3%
DepreciationRs m9401,5201,5602.6%66.0%
InterestRs m8001,2601,3305.6%66.3%
Profit before taxRs m2,5902,0502,75034.1%6.2%
TaxRs m2,01026029011.5%-85.6%
Profit after taxRs m5801,7902,46037.4%324.1%
Gross profit margin%24.325.027.4
Effective tax rate%77.612.710.5
Net profit margin%3.79.412.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 38.9% on a year-on-year (YoY) basis. The expenses were up by 33.3% YoY during the same period.
  • The company's operating profit increased by 56.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.4% in 3QFY19 as against 24.3% in 3QFY18.
  • Depreciation charges increased by 66.0% and finance costs increased by 66.3% YoY, respectively.
  • Other income declined by 95.9% YoY during the quarter.
  • Net profit for the quarter increased by 324.1% YoY. Net profit margins during the quarter increased from 3.7% in 3QFY18 to 12.0% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 4.9% QoQ during the same period.
  • The company's operating profit increased by 18.6% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.4% in 3QFY19 as against 25.0% in 2QFY18.
  • Net profit for the quarter increased by 37.4% QoQ, while net profit margins increased from 9.4% in 2QFY18 to 12.0% in 3QFY19.

To see how TORRENT PHARMA has performed over the last eight quarters, please visit here.

TORRENT PHARMA Share Price Performance

Over the last one year, TORRENT PHARMA share price has moved up from Rs 1,363.0 to Rs 1,821.0, registering a Gain of Rs 458.1 or around 33.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,845.6 (up 0.6%). Over the last one year it has moved down from 14,559.4 to 13,845.6, a gain of 714 points (down 4.9%).

Overall, the S&P BSE SENSEX is up 0.3% over the year.

Current Valuations

At the current price of Rs 1,821.0, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 37.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.7 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

Sensex Nearing All-Time Highs: Stocks to Buy in this Rally(Profit Hunter)

Mar 14, 2019

The BSE Sensex is heating up. In just a few days, the benchmark index is up 3%. Is this rally sustainable? Richa finds out...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Mar 20, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS